ZISHEL

ZISHEL FOUNDATION  is making the unprecedented approaches to tackle the multi-cancer diagnostics via innovative research on t-cell programming.

ZISHEL LABORATOIRE, France has pursued a collaborations with CHAMeditech on the new PDRN (polydeoxyribonucleotide)  induced lipolytic solution. French-made PDRN added onto their patented growth factors. 

Last week in Seoul, Our CEO Jimmy Jongwoo Kim along with President Moon was featured on cover page of Korea's one of the fatest growing financial magazines, ECONOMY VIEW.